iSpecimen (ISPC) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
19 Oct, 2026Executive summary
Supplement dated Oct. 19, 2026, revises the voting standard for the reverse stock split proposal; the adjourned vote is set for Oct. 30, 2026.
Voting on Proposals 1, 3, 4 and 5 concluded Oct. 9; only Proposal 2 remains open, and no other business will be conducted at the adjourned meeting.
Voting matters and shareholder proposals
Proposal 2 passes if votes cast FOR exceed votes cast AGAINST under DGCL Section 242(d)(2); abstentions and unvoted shares have no effect.
Brokers, banks and nominees may vote uninstructed street-name shares on Proposal 2 at their discretion; holders can direct votes by providing voting instructions.
Other ballot matters included Nasdaq approvals for warrant-related share issuance and future financing securities, adjournment authority, and the Foldlab Al asset acquisition; voting concluded Oct. 9.
Proposal 2 votes may be cast or changed online or by phone through 11:59 p.m. ET Oct. 29, or during the virtual meeting Oct. 30; the most recent valid proxy controls.
Board of directors and corporate governance
The Board unanimously recommends voting FOR the reverse stock split proposal and unanimously approved applying the revised voting standard at the adjourned meeting.
Latest events from iSpecimen
- Four proposals cleared preliminary voting; the reverse-split vote stays open through Oct. 30.ISPC
AGM 2026 - Reverse-split vote adjourned to October 30 under a votes-for-must-exceed-against standard.ISPC
Proxy filing - Special Meeting seeks approval for stock issuances, reverse split, and AI asset acquisition.ISPC
Proxy filing - Stockholders will vote on share issuances, a reverse split, and an AI asset acquisition.ISPC
Proxy filing - Revenue fell 83% and net loss widened, raising substantial doubt about going concern status.ISPC
Q2 2026 - Raising up to $5M via best-efforts offering to fund operations, marketing, and platform growth.ISPC
Registration filing - Biospecimen marketplace seeks up to $4M via Nasdaq offering amid ongoing losses and liquidity risks.ISPC
Registration filing - Best-efforts $4M offering targets biospecimen marketplace growth amid ongoing losses and risks.ISPC
Registration filing - Biospecimen marketplace raises $2.5M in private placement; large resale may impact share price.ISPC
Registration filing